Emilia-Romagna Region in Italy launches two new series of HTA documents

08

Dec 2017

Emilia Romagna Region announced the launch of two new series of documents, according to the new regional assessment framework for medical devices developed during 2017: rapid assessment reports and preliminary information reports.

The rapid assessment reports are produced around the experience and methods developed for the short reports series (produced from 2009). The production of this kind of reports takes 3-4 months and involve the clinicians that requested the technology and other regional experts in the field. The reports present the technical characteristics of the technology, its cost, its organizational impact, and estimates the eligible population within the Region. Moreover, a critical analysis of available evidence on effectiveness, safety, and technical performance is carried out. The reports are internally and externally peer-reviewed before publication.

The preliminary information reports are brief documents, typically produced in a very short time, resuming information on the technical characteristics of the technology, indications for use, diffusion, and results of preliminary searches of available evidence. The aim of this kind of reports is to allow establishing if an HTA report needs to be produced or if decisions on the use of the technology can be taken, based on the preliminary information report alone.

The production of both documents is requested by the Regional Committee for Medical Devices, after that permission for use has been requested from clinicians.

See the news in Italian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more